Acknowledged as a major breakthrough, blocking poly (ADP-ribose) polymerase (PARP), a key enzyme in DNA repair, in tumours with genetic or epigenetic abrogation of proteins involved in homologous recombination repair (HRR), creates a synthetic lethal phenotype that kills cancer cells. Here, PARP1 is linked to cancer.